Novo Nordisk | Revenu Net



Net Income Changement Date
ANI Pharmaceuticals USD -10276000 13.89M 2024-12
Aurora Cannabis CAD 31.67M 43.71M 2024-12
Bausch Health Companies USD -85000000 95M 2024-09
Bristol-Myers Squibb USD 72M 1.14B 2024-12
Canopy Growth CAD -121896000 6.4M 2024-12
Corcept Therapeutics USD 30.75M 16.47M 2024-12
Drreddys Laboratories INR 14.13B 1.58B 2024-12
Eli Lilly USD 4.41B 3.44B 2024-12
GlaxoSmithKline GBP 414M 472M 2024-12
Merck USD 3.74B 586M 2024-12
Novartis USD 2.82B 371M 2024-12
Novo Nordisk 27.3B 7.25B 2024-09
Novo Nordisk DKK 27.3B 7.25B 2024-09
Pacira USD 16.04M 159.51M 2024-12
Perrigo USD -44500000 23.5M 2024-12
Prestige Brands USD 61.03M 6.65M 2024-12
Sanofi EUR 2.82B 1.7B 2024-09
Supernus Pharmaceuticals USD 15.33M 23.17M 2024-12
Zoetis USD 581M 101M 2024-12



Novo Nordisk Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.